Results 111 to 120 of about 392,296 (219)

Single-Center Epidemiological Analysis of Malignant Transformation With Skin Ulcers in Outpatients. [PDF]

Int Wound J
Kong Y, Wang H, Cao N, Huai P, Wang Z, Zuo C, Wang X, Wu Y, Liu Y, Chen S, Liu H, Zhang G.   +11 more
europepmc   +1 more source

Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the value of constructing models based on habitat radiomics and pathomics for predicting the risk of progression in high‐grade gliomas. Methods This study conducted a retrospective analysis of preoperative magnetic resonance (MR) images and pathological sections from 72 patients diagnosed with high‐grade gliomas (52 ...
Yuchen Zhu, Yuxi Gong, Weilin Xu, Xingjian Sun, Gefei Jiang, Lei Qiu, Kexin Shi, Mengxing Wu, Yinjiao Fei, Jinling Yuan, Jinyan Luo, Yurong Li, Yuandong Cao, Minhong Pan, Shu Zhou   +14 more
wiley   +1 more source

A YAP/TAZ-CDC6 Axis Initiates and Maintains Malignant Transformation. [PDF]

Cancer Sci
Nduru D, Ohta Y, Nita A, Niimura M, Ngurari S, Moroishi T.   +5 more
europepmc   +1 more source

Unraveling the Molecular Mechanisms of Glioma Recurrence: A Study Integrating Single‐Cell and Spatial Transcriptomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu, Yinjiao Fei, Jiaxuan Ding, Kexin Shi, Jinyan Luo, Yuchen Zhu, Xingjian Sun, Gefei Jiang, Yuandong Cao, Weilin Xu, Shu Zhou   +10 more
wiley   +1 more source

Adhesive hydrogel delivering ALA prevents the malignant transformation of oral leukoplakia. [PDF]

Mater Today Bio
Lin L, Ran J, Zhang Y, Guo S, Yin X, Tang C, Wang Y, Han W, Wang W, Song C.   +9 more
europepmc   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

LncRNA <i>Dlx4os</i> drives malignant transformation and phenotype switching in melanoma. [PDF]

Epigenetics
Ayub ALP, Tonin BCB, Azevedo H, Jordão PHF, Saxena T, Sejour L, Nsengimana J, Vlachos I, Reis EM, Slack FJ, Jasiulionis MG.   +10 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Bioinformatics combined with machine learning for the identification of malignant transformation markers in colorectal polyps. [PDF]

Front Mol Biosci
He T, Liang C, Li K, Li D.
europepmc   +1 more source

Immunogenomic Characterization of Malignant Transformation in Intraductal Papillary Mucinous Neoplasms. [PDF]

Cell Mol Gastroenterol Hepatol
Ecker BL, Sharanappa R, Boukhar SA, Hundeyin M, Leinwand JC, De S, RUTGERS UNIVERSITY IPMN RESEARCH GROUP.   +6 more
europepmc   +1 more source